Mamun, S.A.A. et al. 2021. Rationale of Using Common Antifibrotic Therapy in Post COVID Fibrosis. Journal of Medicine. 22, 1 (Jan. 2021), 46–50. DOI:https://doi.org/10.3329/jom.v22i1.51391.